An Evaluation of The Absolute Bioavailability of TH104
Latest Information Update: 11 Apr 2025
At a glance
- Drugs Nalmefene (Primary)
- Indications Inflammation
- Focus Pharmacokinetics
- Sponsors Tharimmune
Most Recent Events
- 08 Apr 2025 Status changed from active, no longer recruiting to completed.
- 11 Feb 2024 Planned End Date changed from 10 Mar 2024 to 10 Apr 2024.
- 11 Feb 2024 Status changed from recruiting to active, no longer recruiting.